PQQ Reference
Educational, not medical advice reference for PQQ: Nootropic, Longevity; regulatory status, evidence posture, source review, and schedule notes.…
Plain English
- What it is
- PQQ (pyrroloquinoline quinone) is a small antioxidant-type compound that cells use in their energy-making chemical reactions. In the US it is sold as a dietary supplement, not as an FDA-approved medicine.
- What people use it for
- People add it to longevity and brain-focused supplement routines, often alongside CoQ10, because both are linked to how cells produce energy. Some users hope it will sharpen attention and memory or ease tiredness and improve sleep.
- What the science shows
- Most of the energy and mitochondria claims come from animal and lab-dish studies rather than people. The human studies are small and short, and many trace back to the maker of the BioPQQ brand; they report only modest changes in attention, memory, sleep, or fatigue.
- The catch
- The brain benefits are largely unproven and the effects seen so far are small. There is no long-term human safety data, and PQQ is a supplement, not a treatment for any condition.
Reference summary
PQQ is a redox cofactor that the supplement industry markets as a mitochondrial-biogenesis driver based on PGC-1alpha and mitochondrial-DNA-copy-number changes seen in rodent cells and tissue. Human evidence is small and mostly from the Japanese BioPQQ program: randomized placebo-controlled pilot trials in healthy adults (Nakano 2009, Koikeda 2011, Itoh 2016) report modest improvements on attention, working-memory tasks, and self-rated sleep and fatigue, plus changes in oxidative-stress and inflammatory biomarkers. Effect sizes are small and replication outside the manufacturer-aligned literature is limited. No long-term human safety or outcome data exist.
Regulatory and posture
- Categories
- Nootropic, Longevity
- Aliases
- Pyrroloquinoline quinone, Methoxatin, PQQ disodium salt, BioPQQ, MGCPQQ
- Evidence posture
- preclinical - Sold as a dietary supplement, not as an FDA-approved drug. Cognitive and mitochondrial-biogenesis claims rely on small short-duration human pilot trials and rodent mechanistic data. Effect sizes are modest. Not a treatment.
- Regulatory status
- No FDA-approved PQQ drug label. Sold in the US as a dietary supplement, with an FDA New Dietary Ingredient notification on file for the BioPQQ / MGCPQQ disodium salt manufactured by Mitsubishi Gas Chemical. Generic PQQ supplements without that specific NDI letter sit in a less-clear regulatory state.
- Content review status
- research reference
Selected public sources
- PubMed search: pyrroloquinoline quinone (PQQ) cognition and mitochondrial literature
- PubMed search: pyrroloquinoline quinone (BioPQQ) randomized human trials in attention, working memory, and self-rated sleep / fatigue
For research and educational purposes only. Not medical advice.